Rapid Actions of the Nuclear Progesterone Receptor through cSrc in Cancer
The nuclear progesterone receptor (PR) is mainly known for its role as a ligand-regulated transcription factor. However, in the last ten years, this receptor’s extranuclear or rapid actions have gained importance in the context of physiological and pathophysiological conditions such as cancer. The P...
Main Authors: | Claudia Bello-Alvarez, Carmen J. Zamora-Sánchez, Ignacio Camacho-Arroyo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/12/1964 |
Similar Items
-
Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells
by: Claudia Bello-Alvarez, et al.
Published: (2021-03-01) -
Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation
by: Kartik R. Roy, et al.
Published: (2020-11-01) -
Androgen receptor activation inhibits endothelial cell migration in vitro and angiogenesis in vivo
by: Yen-Nien Huo, et al.
Published: (2024-12-01) -
SHP2 is essential for the progesterone-promoted proliferation and migration in breast cancer cell lines
by: Hui-Chen Wang, et al.
Published: (2025-02-01) -
CSRC’s random inspection and capital market information efficiency: an empirical evidence from stock price synchronicity
by: Xue Xia, et al.
Published: (2024-01-01)